NCT06739252 2026-01-28Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCAPeking UniversityPhase 2 Terminated1 enrolled
NCT07353827 2026-01-20FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic CholangiocarcinomaSun Yat-sen UniversityPhase 2 Not yet recruiting36 enrolled
NCT07328919 2026-01-09Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or MutationsTransThera Sciences (Nanjing), Inc.Phase 3 Not yet recruiting138 enrolled
NCT06648525 2024-10-18Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICCHarbin Medical UniversityPhase 2 Not yet recruiting68 enrolled